STOCK TITAN

Teladoc Health Inc Stock Price, News & Analysis

TDOC NYSE

Welcome to our dedicated page for Teladoc Health news (Ticker: TDOC), a resource for investors and traders seeking the latest updates and insights on Teladoc Health stock.

Teladoc Health (TDOC) delivers whole-person virtual care through AI-driven solutions and integrated digital health services. This news hub provides investors and healthcare professionals with essential updates on the company's strategic initiatives, operational milestones, and market developments.

Access real-time information about earnings announcements, technology partnerships, clinical research breakthroughs, and regulatory updates. Our curated collection features official press releases alongside third-party analysis of TDOC's expanding telehealth capabilities and chronic care management innovations.

Key updates include:

• Quarterly financial results
• Strategic acquisitions
• Clinical study outcomes
• Platform enhancements
• Leadership appointments

Bookmark this page for streamlined tracking of Teladoc Health's progress in transforming healthcare delivery through virtual-first solutions. Combine these updates with our comprehensive company profile for informed decision-making in the evolving digital health sector.

Rhea-AI Summary

Teladoc Health has appointed Dr. Vidya Raman-Tangella as Chief Medical Officer, effective April 25, 2022. Dr. Raman-Tangella will spearhead the company's clinical strategy, focusing on health equity, clinical evidence, and physician training. With over two decades of experience, she previously led healthcare solutions at Amazon Web Services. Teladoc aims to enhance patient care through data and technology, affirming its commitment to whole-person virtual care. CEO Jason Gorevic expressed enthusiasm for her leadership in pushing innovation for better health outcomes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.97%
Tags
none
-
Rhea-AI Summary

Teladoc Health has partnered with Northwell Health to enhance virtual care delivery, leveraging its collaboration with Microsoft. This agreement will enable Northwell to utilize Teladoc's platform across 20 hospitals initially, expanding to more affiliates over time. The partnership aims to improve clinical teamwork and patient access to a variety of services, fostering better health outcomes. Teladoc's integrated solution will streamline both consumer and provider interactions, thereby optimizing telehealth programs for enhanced care quality.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.35%
Tags
none
-
Rhea-AI Summary

Teladoc Health (NYSE: TDOC), a leader in virtual healthcare, is set to announce its Q1 2022 results on April 27, 2022, after market close. A conference call hosted by the company will occur at 4:30 p.m. E.T. the same day to discuss these results. U.S. participants can access the call at 1-844-200-6205, while international participants can dial 1-929-526-1599, referencing conference ID #843324. A live audio webcast will also be available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.94%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.29%
Tags
none
-
Rhea-AI Summary

Teladoc Health has launched a pioneering voice-activated general medical virtual care service in collaboration with Amazon Alexa. This innovative feature allows U.S. customers to connect with Teladoc care providers 24/7 using supported Echo devices. Users can initiate a consultation by saying, 'Alexa, I want to talk to a doctor.' Initial consultations will be audio-only, with video visits planned for the future. Costs can be as low as $0 with insurance, or $75 without. This partnership aims to enhance healthcare accessibility and convenience for consumers.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.31%
Tags
none
-
Rhea-AI Summary

Teladoc Health (TDOC) reported a robust fourth quarter revenue increase of 45% year-over-year, reaching $554.2 million. The total visits surged 41% to 4.4 million. For the full year, revenue grew 86% to $2.03 billion with cash flows from operations at $194 million. The company projects 2022 revenue of $2.55 to $2.65 billion, indicating a growth rate of 25% to 30%. Despite a net loss of $11 million in Q4, the adjusted EBITDA rose 53% to $77.1 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.88%
Tags
Rhea-AI Summary

Teladoc Health (NYSE: TDOC) published its annual corporate social responsibility (CSR) report, highlighting its commitment to community service amidst ongoing global challenges. In 2021, approximately 53% of new U.S. hires identified as racial minorities, with a target to increase leadership diversity by 10% in 2022. The company aims to enhance health equity by improving access to culturally aware healthcare. Teladoc also offered free support to communities affected by climate change and exceeded its goal of 10,000 volunteer hours in 2021. The full report is available on their website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.46%
Tags
none
-
Rhea-AI Summary

Teladoc Health (NYSE: TDOC), a leader in whole-person virtual care, announced CEO Jason Gorevic and CFO Mala Murthy will attend the Citi Healthcare Conference on February 24, 2022, and the Cowen Healthcare Conference on March 9, 2022. A live audio webcast and replay will be available on their official investor relations site.

Ranked best in KLAS for Virtual Care Platforms in 2021, Teladoc aims to transform healthcare experiences through personalized interactions and proprietary health signals.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.79%
Tags
conferences
-
Rhea-AI Summary

Teladoc Health has launched Chronic Care Complete, a comprehensive chronic condition management solution aimed at improving health outcomes for individuals living with multiple chronic conditions. The program offers a unified experience combining health monitoring devices, coaching, and support from healthcare professionals, specifically targeting pre-diabetes, diabetes, hypertension, and mental health. Leveraging insights from the 2020 merger with Livongo, this initiative highlights Teladoc's commitment to whole-person care. Chronic Care Complete will be accessible through health plans or employers.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.45%
Tags
none
Rhea-AI Summary

Big Health announces Gabriela Perez as its new Chief Commercial Officer to lead global commercial growth and strategy. With over 20 years of experience in healthcare technology, Perez previously managed significant growth at Ovia Health, which was acquired by Labcorp (NYSE: LH) in August 2021. She also contributed to Best Doctors, acquired by Teladoc Health (NYSE: TDOC) in June 2017. Under her leadership, Big Health aims to enhance coverage and reimbursement for digital therapeutics, leveraging its innovative products proven effective in mental health treatment.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.24%
Tags
none

FAQ

What is the current stock price of Teladoc Health (TDOC)?

The current stock price of Teladoc Health (TDOC) is $7.49 as of September 10, 2025.

What is the market cap of Teladoc Health (TDOC)?

The market cap of Teladoc Health (TDOC) is approximately 1.4B.
Teladoc Health Inc

NYSE:TDOC

TDOC Rankings

TDOC Stock Data

1.39B
174.74M
0.98%
74.49%
13.59%
Health Information Services
Services-offices & Clinics of Doctors of Medicine
Link
United States
NEW YORK